Geriatric Research, Education and Clinical Center (GRECC), VA Palo Alto Health Care System, Palo Alto, CA, United States of America; Division of Endocrinology, Gerontology and Metabolism, Stanford University School of Medicine, Stanford, CA, United States of America.
Geriatric Research, Education and Clinical Center (GRECC), VA Palo Alto Health Care System, Palo Alto, CA, United States of America.
Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165688. doi: 10.1016/j.bbadis.2020.165688. Epub 2020 Jan 24.
In recent years, the prevalence of obesity, metabolic syndrome and type 2 diabetes is increasing dramatically. They share pathophysiological mechanisms and often lead to cardiovascular diseases. The ZDSD rat was suggested as a new animal model to study diabetes and the metabolic syndrome. In the current study, we have further characterized metabolic and hepatic gene expression changes in ZDSD rats. Immuno-histochemical staining of insulin and glucagon on pancreas sections of ZDSD and control SD rats revealed that ZDSD rats have severe damage to their islet structures as early as 15 weeks of age. Animals were followed till they were 26 weeks old, where they exhibited obesity, hypertension, hyperglycemia, dyslipidemia, insulin resistance and diabetes. We found that gene expressions involved in glucose metabolism, lipid metabolism and amino acid metabolism were changed significantly in ZDSD rats. Elevated levels of ER stress markers correlated with the dysregulation of hepatic lipid metabolism in ZDSD rats. Key proteins participating in unfolded protein response pathways were also upregulated and likely contribute to the pathogenesis of dyslipidemia and insulin resistance. Based on its intact leptin system, its insulin deficiency, as well as its timeline of disease development without diet manipulation, this insulin resistant, dyslipidemic, hypertensive, and diabetic rat represents an additional, unique polygenic animal model that could be very useful to study human diabetes.
近年来,肥胖症、代谢综合征和 2 型糖尿病的患病率显著增加。它们具有共同的病理生理机制,常导致心血管疾病。ZDSD 大鼠被认为是研究糖尿病和代谢综合征的新型动物模型。在本研究中,我们进一步研究了 ZDSD 大鼠代谢和肝基因表达的变化。对 ZDSD 和对照 SD 大鼠胰腺切片进行胰岛素和胰高血糖素免疫组织化学染色表明,ZDSD 大鼠早在 15 周龄时就已经对其胰岛结构造成严重损害。动物被跟踪到 26 周龄,此时它们表现出肥胖、高血压、高血糖、血脂异常、胰岛素抵抗和糖尿病。我们发现,ZDSD 大鼠中涉及糖代谢、脂代谢和氨基酸代谢的基因表达显著改变。ZDSD 大鼠中内质网应激标志物水平升高与肝脂代谢失调相关。参与未折叠蛋白反应途径的关键蛋白也上调,可能导致血脂异常和胰岛素抵抗的发病机制。基于其完整的瘦素系统、胰岛素缺乏以及在没有饮食干预的情况下疾病发展的时间进程,这种胰岛素抵抗、血脂异常、高血压和糖尿病大鼠代表了一种额外的、独特的多基因动物模型,对于研究人类糖尿病可能非常有用。